Drawing for HPH

USPTO serial 79094890

HPH

Reviewed by CopyMark Law Group

Reg. 4169712Status 404
Filing date
Status date
Registration date
Jul 10, 2012
Examiner
MARTIN, JENNIFER MCGARRY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam J. Cermak

ADAM J. CERMAK CERMAK NAKAJIMA LLP127 S. PEYTON ST.SUITE 210ALEXANDRIA, VA 22314

Goods and services

ClassDescriptionStatusFirst use
035Advertising, business management, office functions, business management and organization consultancy, business consulting for companies, public relations, marketing; sales promotion; advice to clients on business management and organization; business consulting for companies, namely, advising in the area of corporate strategy in the fields of pharmaceuticals and biotechnology; business consulting for companies, namely, advising in the area of mergers and acquisitions in the fields of pharmaceuticals and biotechnologySECTION 71 - CANCELLED
036Financial consultancy; financial consulting, namely, advising in the field of mergers and acquisition related to pharmaceuticals and biotechnology; financial consulting, namely, advising providing investment advice related to non-organic product portfolio decisions in the fields of pharmaceuticals and biotechnologySECTION 71 - CANCELLED
042Research and development in the pharmaceutical and biotechnology fields; consulting services in the fields of pharmaceutical and biotechnology research, namely, consulting regarding the implementation of clinical test methods; research and development of new productsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 21, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Dec 13, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Nov 5, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 5, 2019INPCINVALIDATION PROCESSED
Oct 15, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 15, 2019C71TCANCELLED SECTION 71
Jul 10, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 19, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Dec 1, 2012GPNXNOTIFICATION PROCESSED BY IB
Oct 10, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 10, 2012FIMPFINAL DISPOSITION PROCESSED
Oct 10, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 10, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2012DOCKASSIGNED TO EXAMINER
Apr 24, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 4, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 4, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 4, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 16, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2012ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 24, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jan 24, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 24, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 7, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2011ALIEASSIGNED TO LIE
Nov 10, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2011RFNTREFUSAL PROCESSED BY IB
May 11, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2011RFRRREFUSAL PROCESSED BY MPU
May 11, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 10, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2011DOCKASSIGNED TO EXAMINER
Apr 12, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Apr 8, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance